Research for Individualized Therapeutics in Rare Genetic Disease

Enrolling by invitation

Conditions studied: Rare Genetic Disease, Undiagnosed Diseases

In brief

The purpose of this research study is to identify individuals that have a rare genetic disease without an adequate therapeutic strategy that might be treatable with drug developed to target the disease-causing genetic alteration.

Key facts

Study ID
NCT05236595
Run by
Mayo Clinic
People needed
50
Starts
2021-11-24
Expected to finish
2026-11-01
Last updated by the study team
2026-01-20

Who can join

Age: any. Sex: any. Healthy volunteers: accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.